A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration /692/699/3161/1626 /692/699/3161/3175 article

• Main Authors: Yamashiro, K, Mori, K, Honda, S
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: angiogenesis inhibitor; ranibizumab; aged; allele; clinical trial; female; genetic marker; genetic predisposition; genetics; genome-wide association study; human; macular degeneration; male; middle aged; multicenter study; odds ratio; severity of illness index; single nucleotide polymorphism; treatment outcome; very elderly; visual acuity; Aged; Aged, 80 and over; Alleles; Angiogenesis Inhibitors; Female; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Macular Degeneration; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Ranibizumab; Severity of Illness Index; Treatment Outcome; Visual Acuity
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178306
• Institution: National University of Singapore

10.1038/s41598-017-09632-0